Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

One-Time Crispr HIV Therapy Given Fast-Track Status

T-cell infected by HIV

A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status

Darpa Seeking On-Demand, Distributed Production of Proteins

Aerial view of the Pentagon in Washington, D.C.

A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins

Venture Fund to Back Life Science A.I. Start-Ups

Synthetic biology

A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups

Trial Underway Testing Dried Plasma for Transfusions

Donated plasma

A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma. . . . → Read More: Trial Underway Testing Dried Plasma for Transfusions

Bio-Friendly Plant Nutrient Delivery Patent Awarded

Seedlings in soil

A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded

Infographic – Venture Funds Continue Slide in Q2

Bar chart: Global venture capital investment dollars by quarter to Q2 2023

Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year. . . . → Read More: Infographic – Venture Funds Continue Slide in Q2

Digital Biomarkers Shown to Highlight Parkinson’s Disease

MRI image of white matter fibers in the brain

Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions. . . . → Read More: Digital Biomarkers Shown to Highlight Parkinson’s Disease

A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds

Smart home graphic

A company developing area sensors for smart homes that combine WiFi technology with machine learning algorithms is raising $10.5 million in venture funds. . . . → Read More: A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds

Biochip Device Tests Malaria Drug Efficacy, Safety

Malaria model chip device

A lab-on-a-chip device with human organ cells is shown in lab tests to distinguish between malaria strains and detect drug toxicity when assessing blood for seven days. . . . → Read More: Biochip Device Tests Malaria Drug Efficacy, Safety

Synthetic DNA Company Gains $10M in Venture Round

Steve Harvey and Derek Stemple in the lab

A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round